Ibrexafungerp: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* A triterpenoid glycoside enfumafungin which inhibits glucan synthase * Indicated for ''Candida'' infections, and also has activity against ''Aspergillus'' * Dosing:..." |
(No difference)
|
Latest revision as of 11:57, 4 July 2020
- A triterpenoid glycoside enfumafungin which inhibits glucan synthase
- Indicated for Candida infections, and also has activity against Aspergillus
- Dosing:
- 1000 mg po load followed by 500 mg po daily
- 1250 mg po load followed by 750 mg po daily
- 750 mg po bid x2 (load) followed by 750 mg po daily
